| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2019 | Aug 22, 2019 | Aquestive Therapeutics, Inc. | Director | Buy | 95.0 | +22,971 | 265.13% | ✗ | $87K |
| Sep 7, 2017 | Sep 7, 2017 | Matinas BioPharma Holdings, Inc. | Director | Buy | 77.5 | +5,000 | 1.21% | ✗ | $6.5K |
| Jun 5, 2017 | Jun 7, 2017 | Pacira BioSciences, Inc. | President | Sell | 22.5 | -1,966 | -7.26% | ✗ | $85.2K |
| May 15, 2017 | May 17, 2017 | Pacira BioSciences, Inc. | President | Sell | 5.0 | -20,000 | -42.48% | ✓ | $1M |
| Jan 17, 2017 | Jan 19, 2017 | Pacira BioSciences, Inc. | President | Sell | 7.5 | -20,000 | -42.48% | ✓ | $770.7K |
| Nov 15, 2016 | Nov 17, 2016 | Pacira BioSciences, Inc. | President | Sell | 7.5 | -20,000 | -42.48% | ✓ | $730K |
| Aug 15, 2016 | Aug 17, 2016 | Pacira BioSciences, Inc. | President | Sell | 5.0 | -25,000 | -48.00% | ✓ | $1.1M |
| Sep 11, 2015 | Sep 14, 2015 | Pacira BioSciences, Inc. | CFO | Buy | 97.5 | +5,000 | 90.84% | ✗ | $306.9K |
| Feb 6, 2015 | Feb 9, 2015 | Pacira BioSciences, Inc. | CFO | Sell | 5.0 | -15,000 | -74.15% | ✓ | $1.7M |
| Nov 7, 2014 | Nov 12, 2014 | Pacira BioSciences, Inc. | CFO | Sell | 5.0 | -15,000 | -75.00% | ✓ | $1.3M |
| Aug 8, 2014 | Aug 11, 2014 | Pacira BioSciences, Inc. | CFO | Sell | 5.0 | -15,000 | -75.00% | ✓ | $1.5M |
| May 8, 2014 | May 9, 2014 | Pacira BioSciences, Inc. | CFO | Sell | 5.0 | -15,000 | -75.00% | ✓ | $1.1M |
| Dec 30, 2013 | Jan 2, 2014 | Pacira BioSciences, Inc. | CFO | Sell | 7.5 | -10,000 | -66.67% | ✓ | $555.5K |
| Sep 30, 2013 | Oct 2, 2013 | Pacira BioSciences, Inc. | CFO | Sell | 7.5 | -10,000 | -66.67% | ✓ | $467.4K |
| Jun 28, 2013 | Jul 2, 2013 | Pacira BioSciences, Inc. | CFO | Sell | 7.5 | -10,000 | -66.67% | ✓ | $280.5K |
| Mar 28, 2013 | Apr 1, 2013 | Pacira BioSciences, Inc. | CFO | Sell | 7.5 | -10,000 | -66.67% | ✓ | $284.9K |